Lolkje TW De Jong - van den Berg

Summary

Affiliation: University of Groningen
Country: The Netherlands

Publications

  1. pmc Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study
    Janneke Jentink
    Department of Pharmacoepidemiology and Pharmacoeconomics, Division of Pharmacy, University of Groningen, Netherlands
    BMJ 341:c6581. 2010
  2. ncbi request reprint HRT use in 2001 and 2004 in The Netherlands--a world of difference
    Lolkje T W de Jong-van den Berg
    Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Maturitas 54:193-7. 2006
  3. doi request reprint Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    H Dolk
    Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands, Ant Deusinglaan 1, 9713 AV Groningen The Netherlands
    Neurology 71:714-22. 2008
  4. pmc Patient-reporting of side effects may provide an important source of information in clinical practice
    Juliet M Foster
    Eur J Clin Pharmacol 63:979-80; author reply 981. 2007
  5. pmc Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial
    Janna M Munster
    University of Groningen, University Centre for Pharmacy, Pharmacoepidemiology and Pharmacoeconomics, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Womens Health 10:32. 2010

Collaborators

  • Ester Garne
  • Ingeborg Barisic
  • Adrianne Faber
  • H Dolk
  • Catherine De Vigan
  • Annette Queisser-Luft
  • Lolkje T W de Jong-van den Berg
  • Janneke Jentink
  • Janna M Munster
  • Juliet M Foster
  • Simone Poetzsch
  • Joan K Morris
  • Jerome R Lo-Ten-Foe
  • Jamie Meekelenkamp
  • Anna Pierini
  • Marian Bakker
  • Albertus Timmer
  • Vera Nelen
  • David Tucker
  • Jan P Mejnartowicz
  • Isabel Portillo
  • Ariene Rietveld
  • Berenice Doray
  • Carl J C M Hamilton
  • Kari Melve
  • Awi Wiesel
  • Eelko Hak
  • Ronald P Stolk
  • Peter M Schneeberger
  • Babak Khoshnood
  • Josien Riphagen-Dalhuisen
  • Christine Verellen-Dumoulin
  • Miriam Gatt
  • Wim van der Hoek
  • Mary O'Mahony
  • Jan G Aarnoudse
  • Esther De Vries
  • Marie Claude Addor
  • Anna Latos-Bielenska
  • Alexander C A P Leenders
  • Francesca Rivieri
  • Diana Wellesley
  • Maria A Loane
  • Thys van der Molen

Detail Information

Publications5

  1. pmc Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study
    Janneke Jentink
    Department of Pharmacoepidemiology and Pharmacoeconomics, Division of Pharmacy, University of Groningen, Netherlands
    BMJ 341:c6581. 2010
    ..To identify specific major congenital malformations associated with use of carbamazepine in the first trimester of pregnancy...
  2. ncbi request reprint HRT use in 2001 and 2004 in The Netherlands--a world of difference
    Lolkje T W de Jong-van den Berg
    Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
    Maturitas 54:193-7. 2006
    ..Therefore, we compare the prescribing of HRT in 2004 (after) with that of 2001 (before the publications) in The Netherlands...
  3. doi request reprint Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    H Dolk
    Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands, Ant Deusinglaan 1, 9713 AV Groningen The Netherlands
    Neurology 71:714-22. 2008
    ....
  4. pmc Patient-reporting of side effects may provide an important source of information in clinical practice
    Juliet M Foster
    Eur J Clin Pharmacol 63:979-80; author reply 981. 2007
  5. pmc Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial
    Janna M Munster
    University of Groningen, University Centre for Pharmacy, Pharmacoepidemiology and Pharmacoeconomics, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    BMC Womens Health 10:32. 2010
    ..We designed a trial to assess the (cost-)effectiveness of a screening program for Q fever in pregnant women living in risks areas in The Netherlands...